1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B1774597E5612F2A00258BCF002B3F20
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-improving-medical-affairs-booth-impact-performance-measurement-msl-content?opendocument
18
19opendocument
2018.97.9.168
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Best Practices in Improving Medical Affairs Booth Impact: Performance Measurement and Innovative MSL Content

ID: 5836


Features:

7 Info Graphics

13 Data Graphics

200+ Metrics


Pages/Slides: 27


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Best Practices in Improving Medical Affairs Booth Impact: Performance Measurement and Innovative MSL Content”

STUDY OVERVIEW

To maximize the effectiveness of their medical booths at major congresses, biopharma companies are increasingly focused on measuring performance while also innovating in MSL-led content sharing. Medical Science Liaisons (MSLs) play a crucial role in engaging healthcare professionals by providing timely, relevant information at these events.

This benchmarking study by Best Practices, LLC explores how biopharma companies enhance their medical booth strategies, offering actionable insights on the metrics and performance evaluation practices that leading organizations use to gauge impact. Additionally, it highlights innovative methods MSLs are using to engage HCPs, including the latest types of field-ready medical content that resonate at congresses.

KEY TOPICS

  • Measuring Medical Booth Success
  • Best Practices and Common Pitfalls in Booth Content Display
  • Medical Content Utilized by MSLs in the Field

KEY METRICS

  • Successful strategies used to capture congress audience attention
  • Metrics for evaluating the impact and effectiveness of medical booth content
  • Comparison of most valuable vs. most used metrics for measuring the value of medical information/medical affairs booth content
  • Channels used to distribute posters and content to congress attendees
  • Permissions for e-mail distribution of booth content to congress attendees
  • Innovative materials used by MSLs in the field and sharing methods (proactive vs. reactive)
  • Content availability and sharing methods at congress events
  • Adopting innovative MSL materials
  • Innovative booth information shared by MSLs
  • MSL utilization of poster books in the field
  • MSL-hosted receptions at medical congress events and attendee criteria

SAMPLE KEY FINDINGS

  • Field Team Support of Medical Booth: 50% of MSLs use poster books to disseminate important information from key congresses from the past year.

METHODOLOGY

Best Practices, LLC collaborated with 20 leaders in Medical Communications and Scientific Publications from 17 biopharma companies for this comprehensive study. A quantitative survey served as the primary data collection method, supplemented by qualitative insights to enhance the findings.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.